The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Increasing women's sexual desire: The comparative effectiveness of estrogens and androgens
Open accessAbstract
Both estradiol and testosterone have been implicated as the steroid critical for modulating women’s sexual desire. By contrast, in all other female mammals only estradiol has been shown to be critical for female sexual motivation and behavior. Pharmaceutical companies have invested heavily in the development of androgen therapies for female sexual desire disorders, but today there are still no FDA approved androgen therapies for women. Nonetheless, testosterone is currently, and frequently, prescribed off-label for the treatment of low sexual desire in women, and the idea of testosterone as a cure-all for female sexual dysfunction remains popular. This paper places the ongoing debate concerning the hormonal modulation of women’s sexual desire within a historical context, and reviews controlled trials of estrogen and/or androgen therapies for low sexual desire in postmenopausal women. These studies demonstrate that estrogen-only therapies that produce periovulatory levels of circulating estradiol increase sexual desire in postmenopausal women. Testosterone at supraphysiological, but not at physiological, levels enhances the effectiveness of low-dose estrogen therapies at increasing women’s sexual desire; however, the mechanism by which supraphysiological testosterone increases women’s sexual desire in combination with an estrogen remains unknown. Because effective therapies require supraphysiological amounts of testosterone, it remains unclear whether endogenous testosterone contributes to the modulation of women’s sexual desire. The likelihood that an androgen-only clinical treatment will meaningfully increase women’s sexual desire is minimal, and the focus of pharmaceutical companies on the development of androgen therapies for the treatment of female sexual desire disorders is likely misplaced.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.
Shifren, J. L., Braunstein, G. D., Simon, J. A., Casson, P. R., Buster, J. E., Redmond, G. P., Burki, R. E., Ginsburg, E. S., Rosen, R. C., Leiblum, S. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431002 · Cited by 954
Meston, C. M., & Buss, D. M. (2007) · Archives of Sexual Behavior · doi:10.1007/s10508-007-9175-2 · Cited by 781 · cited 1×
“…does not necessarily reflect women’s sexual desire (Wallen, 2001) – women can (and do) engage in sexual intercourse for reasons other than their own sexual desire, and frequency of heterosexual intercourse may be heavily influenced by male sexual motivation (Meston & Buss, 2007; Wallen, 2001).”
BackgroundEffects of estrogen plus progestin on health-related quality of life
Hays, J., Ockene, J. K., Brunner, R. L., Kotchen, J. M., Manson, J. E., Patterson, R. E., Aragaki, A. K., Shumaker, S. A., Brzyski, R. G., LaCroix, A. Z., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030311 · Cited by 686
Simon, J., Braunstein, G., Nachtigall, L., Utian, W., Katz, M., Miller, S., Waldbaum, A., Bouchard, C., Derzko, C., Buch, A., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1747 · Cited by 475
Braunstein, G. D., Sundwall, D. A., Katz, M., Shifren, J. L., Buster, J. E., Simon, J. A., Bachman, G., Aguirre, O. A., Lucas, J. D., Rodenberg, C., et al. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.14.1582 · Cited by 458
Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle
ABRAHAM, G. E. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-39-2-340 · Cited by 436
The role of androgen in the maintenance of sexual functioning in oophorectomized women.
Sherwin, B. B., & Gelfand, M. M. (1987) · Psychosomatic Medicine · doi:10.1097/00006842-198707000-00009 · Cited by 394 · cited 12×
“…of an estrogen therapy at increasing sexual desire in postmenopausal women (Burger et al., 1987; Flöter et al., 2002; Sherwin et al., 1985; Sherwin & Gelfand, 1987; Braunstein et al., 2005; Buster et al., 2005; Davis et al., 2006b; Panay et al., 2010; Shifren et al., 2006; Simon et al.,…”
BackgroundMethodInfluentialHormonal predictors of sexual motivation in natural menstrual cycles
Roney, J. R., & Simmons, Z. L. (2013) · Hormones and Behavior · doi:10.1016/j.yhbeh.2013.02.013 · Cited by 348
Davis, S. R., van der Mooren, M. J., van Lunsen, R. H. W., Lopes, P., Ribot, J., Rees, M., Moufarege, A., Rodenberg, C., Buch, A., & Purdie, D. W. (2006) · Menopause · doi:10.1097/01.gme.0000179049.08371.c7 · Cited by 250
Sex and context: hormones and primate sexual motivation
Wallen, K. (2001) · Hormones and Behavior · doi:10.1006/hbeh.2001.1696 · Cited by 218
Self-citation
Cited by
Bell, M. R. (2018) · Endocrinology · doi:10.1210/en.2018-00220 · Cited by 308
Soman, M., Huang, L.-C., Cai, W.-H., Xu, J.-B., Chen, J.-Y., He, R.-K., Ruan, H.-C., Xu, X.-R., Qian, Z.-D., & Zhu, X.-M. (2019) · Menopause · doi:10.1097/gme.0000000000001161 · Cited by 63
Estrogenic regulation of social behavior and sexually dimorphic brain formation
Ogawa, S., Tsukahara, S., Choleris, E., & Vasudevan, N. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.10.012 · Cited by 60
Metadata
- Authors
- Cappelletti, M., & Wallen, K.
- Venue
- Hormones and Behavior
- Publisher
- Elsevier BV
- Published
- 2016-02
- Volume
- 78
- Pages
- 178-193
- ISSN
- 0018-506X (ISSN-L)
- OpenAlex
- W2214651295
- Cited by
- 169
- References
- 11
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increasing women's sexual desire: The comparative effectiveness of estrogens and androgens. https://app.cochat.ai/papers/10.1016/j.yhbeh.2015.11.003
- The paper
- Cappelletti, M., & Wallen, K. (2016). Increasing women's sexual desire: The comparative effectiveness of estrogens and androgens. Hormones and Behavior. https://doi.org/10.1016/j.yhbeh.2015.11.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.